TerminatedPhase 4NCT03237182

The Individualized M(X) Drug-resistant TB Treatment Strategy Study

Studying Tuberculosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centre for the AIDS Programme of Research in South Africa
Principal Investigator
Nesri Padayatchi, MBChB, PhD
Centre for the AIDS Programme of Research in South Africa
Intervention
Individualized TB treatment with multiple drugs(drug)
Enrollment
205 enrolled
Eligibility
18 years · All sexes
Timeline
2017 – 2022

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03237182 on ClinicalTrials.gov

Other trials for Tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Tuberculosis →

← Back to all trials